Robert Gillis, MD
Orthopaedic Surgery · Gettysburg, PANPI 1730389545
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.8%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Arthrex at 53.8% of the total. Reporting peaked in 2020 at $2,000 and has fallen 83.2% since, to $337 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in PA, where the typical reported total is $3,243.
Across 20 payments — averaging $185.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Zimmer Biomet$654
- Hikma Pharmaceuticals USA$423
- Novus Surgical Consultants$397
- Stryker$103
- Acumed LLC$74
- plus $66 from 1 others
What the payments were for
- Consulting fees$42311%
- Speaking & faculty fees$2,00054%
- Food & beverage$99927%
- Education$2968%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 1 | $2,000 |
| Zimmer Biomet | 7 | $654 |
| Hikma Pharmaceuticals USA | 1 | $423 |
| Novus Surgical Consultants | 4 | $397 |
| Stryker | 5 | $103 |
| Acumed LLC | 1 | $74 |
| Avita Medical Americas, LLC | 1 | $66 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COMBOGESIC IV$423
- PSI bone models$144
- Persona Revision$143
How this compares
$3,718 in reported general payments places this provider in the 50th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 294 | $6,397 |
| Naloxone Hcl | 23 | $1,508 |
| Diclofenac Sodium | 119 | $1,402 |
| Oxycodone Hcl | 210 | $954 |
| Ibuprofen | 83 | $767 |
| Ondansetron Hcl | 120 | $427 |
| Doxycycline Hyclate | 34 | $337 |
| Gabapentin | 17 | $274 |
| Tramadol Hcl | 80 | $217 |
| Methylprednisolone | 31 | $190 |
| Amoxicillin | 104 | $135 |
| Ondansetron OdtOndansetron | 15 | $93 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $65 |
| Cephalexin | 21 | $53 |
| Clindamycin Hcl | 38 | $34 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Gettysburg
- William HozackBensalem$10.6M
- Jess LonnerBryn Mawr$7.8M
- Gerald WilliamsBryn Mawr$6.8M
- Mark LazarusBensalem$6.4M
- John FenlinPhiladelphia$5.9M
- Peter SharkeyKing Of Prussia$5.7M
- Alexander VaccaroPhiladelphia$4.5M
- Selene ParekhBensalem$4.5M
- Joseph AbboudPhiladelphia$3.9M
- Jonathan GarinoMalvern$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.